Farrerol prevents Angiotensin II-induced cardiac remodeling <i>in vivo</i> and <i>in vitro</i>.

He, Jian; Xu, Dengyue; Wang, Lu; Yu, Xiaohong

Farrerol prevents Angiotensin II-induced cardiac remodeling in vivo and in vitro.

He, Jian; Xu, Dengyue; Wang, Lu; Yu, Xiaohong.

Afiliación

He J; Department of Cardiovascular Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Xu D; Department of Cardiovascular Surgery, General Hospital of Northern Theater Command of China Medical University, Shenyang, China.
Wang L; Department of Cardiovascular Surgery, General Hospital of Northern Theater Command of China Medical University, Shenyang, China.
Yu X; Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.

Front Pharmacol ; 13: 1079251, 2022.

Article en En | MEDLINE | ID: mdl-36686707

Palabras clave

Farrerol; fibrosis; inflammation; myocardial remodeling; oxidative stress

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google